Navigation Links
Max Neeman International Signs Agreement for Data Management/EDC of Large Phase IV Trials from Multiple Sites
Date:5/12/2010

RESEARCH TRIANGLE PARK, N.C., May 12 /PRNewswire/ -- The International Collaborative Cancer Group, in collaboration with the Institute of Cancer Research Clinical Trials and Statistics Unit, is running the Intergroup Exemestane Study (IES).  IES is a randomized, double blind multinational trial of post menopausal women with early breast cancer and a median follow-up period of 91 months. Max Neeman will be responsible for the compilation of the data from multiple centers.

This landmark trial has the longest follow-up of endocrine treatment in the adjuvant switch setting with approximately 2300 patients from across the globe.  The study evaluates the clinical benefits of switching over to Aromasin after two to three years of Tamoxifen in comparison with patients put on only Tamoxifen for a full, five year period.

Max Neeman provides Data Management/EDC service for large Phase IV multicentric trials to companies across the globe, in 60 countries to date.  Max Neeman also conducts post-marketing observational studies for multiple indications of hypertension, contact dermatitis, acute coronary syndrome, cessation of smoking, renal carcinoma, breast carcinoma, age related macular degeneration and fungal infections.  

About Max Neeman International

Max Neeman International is one of the leading and largest CROs in India. Our specialty is that we offer services for the successful conduct of Phase I-IV clinical and device trials for small and mid-sized international and national Pharmaceutical, Biotechnology, Medical Device and Nutraceutical companies in compliance with ICH GCP standards. Operational since 2001, Max Neeman is an ISO 9001:2008 certified CRO for Monitoring, Site Management and Data Management Services. The company is presently active in 22 cities with 5 regional offices.  Contact Donald Swankie, Vice President of Business Development, for more information via email to donald.swankie@neeman-medical.com or call +1.919.424.3345.  For more information please visit www.neeman-medical.com.


'/>"/>
SOURCE Max Neeman International
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Max Neeman International to Open Phase I/IIa Unit
2. China Sky One Medical Attended Import and Export Fair to Enhance International Growth Opportunity
3. Yongye International Announces Conference Call to Discuss First Quarter Fiscal Year 2010 Results
4. Dyadic International to Present at Rodman & Renshaw 6th Annual Global Healthcare Conference
5. Yongye International to Present at Upcoming Investor Conferences
6. Yongye International, Inc. Begins Construction of New Production Facility
7. Microfluidics International Corporation to Report First Quarter 2010 Financial Results on May 11, 2010
8. Dyadic International Strengthens Management Team
9. PharmAthene CEO To Participate on Biosecurity Panel at the 2010 BIO International Conference
10. Regado Biosciences to Present at the BIO International Convention Held in Chicago, Illinois on May 5, 2010
11. Frommer Lawrence & Haugs Thomas J. Kowalski Named to the International Whos Who of Patent Attorneys
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of 8.5 ... end machines that use the more unconventional z-dimension of 20mm. Z-dimension or ... the cuvette holder. , FireflySci has developed several Agilent flow cell product lines ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)... Lawrence, MA (PRWEB) , ... June 23, 2016 ... ... the Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research ... test platform of microbial tests introduced last year,” stated Bob Salter, Vice President ...
(Date:6/23/2016)... ... , ... Supplyframe, the Industry Network for electronics hardware design ... Located in Pasadena, Calif., the Design Lab’s mission is to bring together inventors ... and brought to market. , The Design Lab is Supplyframe’s physical representation of ...
Breaking Biology Technology:
(Date:4/15/2016)... , April 15, 2016  A new partnership ... more accurate underwriting decisions in a fraction of ... competitively priced and high-value life insurance policies to ... With Force Diagnostics, rapid testing (A1C, ... data readings (blood pressure, weight, pulse, BMI, and ...
(Date:3/31/2016)... Florida , March 31, 2016 ... ) ("LegacyXChange" or the "Company") LegacyXChange ... potential users of its soon to be launched online ... ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential ... use of DNA technology to an industry that is ...
(Date:3/22/2016)... , March 22, 2016 ... report "Electronic Sensors Market for Consumer Industry by Type ... Others), Application (Communication & IT, Entertainment, Home ... Global Forecast to 2022", published by MarketsandMarkets, ... expected to reach USD 26.76 Billion by ...
Breaking Biology News(10 mins):